Immunizations

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. (AP Photo/Hans Pennink)
August 02, 2020 - 7:05 am
Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National Institutes of Health...
Read More
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, adjusts his face mask during a House Subcommittee on the Coronavirus crisis hearing, Friday, July 31, 2020 on Capitol Hill in Washington. (Kevin Dietsch/Pool via AP)
July 31, 2020 - 4:23 pm
WASHINGTON (AP) — Dr. Anthony Fauci said Friday that he remains confident that a coronavirus vaccine will be ready by early next year, telling lawmakers that a quarter-million Americans already have volunteered to take part in clinical trials. But if the future looks encouraging, public health...
Read More
FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)
July 31, 2020 - 12:46 pm
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2.1 billion “for...
Read More
Leon McFarlane a research technician handles a blood sample from a volunteer in the laboratory at Imperial College in London, Thursday, July 30, 2020. Imperial College is working on the development of a COVID-19 vaccine. Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in those vaccinated so far. Dr. Robin Shattock told the Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in a small number of participants and would now be expanding the trial to about 300 people, including those over 75. (AP Photo/Kirsty Wigglesworth)
July 30, 2020 - 3:49 pm
LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr. Robin Shattock, a professor at the college, told The Associated...
Read More
FILE - In this Saturday, July 18, 2020 file photo a general view of AstraZeneca offices and the corporate logo in Cambridge, England. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. "We are seeing good immune response in almost everybody," said Dr. Adrian Hill. Hill said Oxford has partnered with drugmaker AstraZeneca to produce their vaccine globally, and that the company has already committed to making 2 billion doses. (AP Photo/Alastair Grant, File)
July 30, 2020 - 12:54 pm
LONDON (AP) — Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales...
Read More
Steve, right, and Chris Brophy, husband and wife owners of Brickley's Ice Cream, look out from the store they closed after teenage workers were harassed by customers who refused to wear a mask or socially distance, in Wakefield, R.I., Wednesday, July 29, 2020. "Some of them don't believe it's real (COVID-19) and some don't think it's a big deal, I do," Steve Brophy said, adding that he would rather close than put young workers and customers at risk of harassment, and the virus. "It's like it's OK to be a jerk in this environment." (AP Photo/David Goldman)
July 29, 2020 - 7:54 pm
PROVIDENCE, R.I. (AP) — As the world races to find a vaccine and a treatment for COVID-19, there is seemingly no antidote in sight for the burgeoning outbreak of coronavirus conspiracy theories, hoaxes, anti-mask myths and sham cures. The phenomenon, unfolding largely on social media, escalated...
Read More
Vice President Mike Pence, center, gestures as he speaks during a news conference with Food and Drug Administration Commissioner Dr. Stephen Hahn, left, and Florida Gov. Ron DeSantis, right, at the University of Miami Miller School of Medicine Don Soffer Clinical Research Center, Monday, July 27, 2020, in Miami. Pence was in Florida to mark the beginning of Phase III trials for a coronavirus vaccine. (AP Photo/Wilfredo Lee)
July 29, 2020 - 12:40 pm
RALEIGH, N.C. (AP) — Vice President Mike Pence traveled to Raleigh on Wednesday in a push to encourage more K-12 schools to reopen with entirely in-person instruction. Air Force Two landed around noon on Wednesday at Raleigh-Durham International Airport ahead of planned stops at a private school...
Read More
Connecticut Gov. Ned Lamont speaks at a press conference at Pfizer Groton on the companies research to develop a vaccine for COVID-19, Wednesday, July 22, 2020, in Groton, Conn. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Stew Milne)
July 28, 2020 - 9:45 am
FAIRLESS HILLS, Pa. (AP) — Pfizer Inc. reported a 32% plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and new prescriptions for its medicines. Pfizer had predicted in April that the virus would keep both patients and company sales representatives...
Read More
Gao Fu, the head of the Chinese Center for Disease Control and Prevention (China CDC), speaks to journalists after a press conference at the State Council Information Office in Beijing on Jan. 26, 2020. Gao has revealed Tuesday, July 28, 2020 he has been injected with an experimental coronavirus vaccine in what he said is an attempt to persuade the public to follow suit when one is approved. (AP Photo/Mark Schiefelbein)
July 28, 2020 - 2:51 am
BEIJING (AP) — The head of the Chinese Center for Disease Control and Prevention says he has been injected with an experimental coronavirus vaccine in an attempt to persuade the public to follow suit when one is approved. “I’m going to reveal something undercover: I am injected with one of the...
Read More
People wearing face masks to protect against the coronavirus wait to cross an intersection in Beijing, Saturday, July 25, 2020. China on Saturday reported several dozen new confirmed coronavirus cases, including a few who caught the virus abroad. (AP Photo/Mark Schiefelbein)
July 27, 2020 - 9:32 pm
BEIJING — New coronavirus cases continue to rise in China’s northwestern region of Xinjiang, with 57 reported on Tuesday. The capital Beijing also reported its first case of domestic transmission in more than two weeks, while the northeastern province of Liaoning added another six cases in its...
Read More

Pages